Cargando…

Peanut Oral Immunotherapy: a Current Perspective

PURPOSE OF THE REVIEW: Peanut oral immunotherapy (OIT) is one of the most studied experimental therapies for food allergy. With the recently FDA-approved peanut product, Palforzia, the goal of this article is to review the most recent data from clinical trials, discuss recent trends, and anticipate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patrawala, Meera, Shih, Jennifer, Lee, Gerald, Vickery, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Food Allergy (E Kim, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223701/ https://www.ncbi.nlm.nih.gov/pubmed/32314071 http://dx.doi.org/10.1007/s11882-020-00908-6

Ejemplares similares

Real-World LEAP Implementation
por: Koplin, Jennifer J., et al.
Publicado: (2022)

Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
por: Brown, Sara J., et al.
Publicado: (2011)

Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand
por: Wanniang, Naphisabet, et al.
Publicado: (2023)

Patients’ Perspectives and Needs on Novel Food Allergy Treatments in the United States
por: Herbert, Linda, et al.
Publicado: (2021)

Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp
por: Leonard, Stephanie A., et al.
Publicado: (2022)

Using Component-Resolved Diagnostics in the Management of Peanut-Allergic Patients
por: van Erp, F. C., et al.
Publicado: (2016)

Defining the window of opportunity and target populations to prevent peanut allergy
por: Roberts, Graham, et al.
Publicado: (2023)

Peanut butter feeding induces oral tolerance in genetically diverse collaborative cross mice
por: Immormino, Robert M., et al.
Publicado: (2023)

Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6
por: Hemmings, Oliver, et al.
Publicado: (2020)

Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
por: Leef, Chelsea, et al.
Publicado: (2022)

Peanut diversity and specific activity are the dominant IgE characteristics for effector cell activation in children
por: Hemmings, Oliver, et al.
Publicado: (2021)

Food Allergies: The Basics
por: Valenta, Rudolf, et al.
Publicado: (2015)

IgG(4) inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens
por: Santos, Alexandra F., et al.
Publicado: (2015)

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020)

Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
por: Brough, Helen A., et al.
Publicado: (2014)

Preclinical evaluation of alternatives to oral immunotherapy for food allergies
por: Johnson-Weaver, Brandi T.
Publicado: (2023)

Determination of Allergen Levels, Isoforms, and Their Hydroxyproline Modifications Among Peanut Genotypes by Mass Spectrometry
por: Marsh, Justin T., et al.
Publicado: (2022)

Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children
por: Santos, Alexandra F., et al.
Publicado: (2014)

Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles
por: Datema, Mareen R., et al.
Publicado: (2021)

Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy
por: Hughes, Kevin R., et al.
Publicado: (2022)

Differences in Linear Epitopes of Ara h 9 Recognition in Peanut Allergic and Tolerant, Peach Allergic Patients
por: Sánchez-Ruano, L., et al.
Publicado: (2022)

Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022)

Mechanisms for Alternaria alternata Function in the Skin During Induction of Peanut Allergy in Neonatal Mice With Skin Barrier Mutations
por: Buelow, Lauren M., et al.
Publicado: (2021)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

IgE epitopes of Ara h 9, Jug r 3, and Pru p 3 in peanut-allergic individuals from Spain and the US
por: Kronfel, Christina M., et al.
Publicado: (2023)

Skin prick test in milk allergic patients undergoing oral immunotherapy: Does the milk form used for skin tests matter?
por: Bukhari, Esraa, et al.
Publicado: (2022)

Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut
por: Santos, Alexandra F., et al.
Publicado: (2015)

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach
por: Marcucci, Maura, et al.
Publicado: (2013)

Grand Challenges in Allergen Immunotherapy
por: Cox, Linda
Publicado: (2021)

Clinical Considerations of Ultra-processed Food Addiction Across Weight Classes: an Eating Disorder Treatment and Care Perspective
por: Wiss, David
Publicado: (2022)

Mast Cell Desensitization in Allergen Immunotherapy
por: López-Sanz, Celia, et al.
Publicado: (2022)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity
por: Amoah, Abena S., et al.
Publicado: (2013)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
por: De Carli, Marco, et al.
Publicado: (2023)

Review: The Nose as a Route for Therapy. Part 2 Immunotherapy
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
por: Jakwerth, Constanze A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9j8sqogul1t4e8b6u8mh5nsnnh